Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd (GLAXO) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 1,58,911
Apr 25, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹2,802.70
₹-113.30 (-3.89%)
2,780.00Low
Today’s Performance
2,944.80High
1,921.00Low
52 Week’s Performance
3,148.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-3.89%
  • 1 Week-0.45%
  • 1 Month-1.11%
  • 3 Months35.90%
  • 6 Months8.27%
  • 1 Year35.68%
  • 3 Years20.91%
  • 5 Years14.19%

bt_logoPeer Comparison

Price

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.73
  • 52-Week Low (₹)1,921.00
  • 52-Week High (₹)3,148.00
  • Price-to-Book (X)*28.40
  • Dividend Yield (%)1.14
  • Price-to-Earnings (P/E) (X)*55.28
  • Earnings Per Share (₹)50.72
  • Market Cap (₹ Cr.)*47,479.43
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Trump Tariff| Kenneth Andrade on India’s Resilience Amid Trade Uncertaint1:33Trump Tariff | Kenneth Andrade on India’s Resilience Amid Trade Uncertainty
Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy4:38Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy
Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan5:16Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan
Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream0:54Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream
From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty1:43From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty
Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals2:58Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals
Domestic Focus, Global Reach: Jindal Stainless8:54Domestic Focus, Global Reach: Jindal Stainless
Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices3:40Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices
Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report19:05Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report
India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop8:47India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

17 Oct, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty80615
Average Price₹1378.65
17 Oct, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty80615
Average Price₹1378.65
17 Oct, 2022SELL
ISHARES INDIA SC MAURITIUS COMPANY
Qty11841
Average Price₹1378.65
17 Oct, 2022BUY
ISHARES MSCI INDIA SMALL-CAP ETF
Qty11841
Average Price₹1378.65
11 Oct, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty77734
Average Price₹1393.45
11 Oct, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty77734
Average Price₹1393.45
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Glaxosmithkline Pharmaceuticals Ltd share price previously?
Glaxosmithkline Pharmaceuticals Ltd share price was down by -3.89% from the previous closing price of ₹2,916.00.
Who are peers of Glaxosmithkline Pharmaceuticals Ltd?
The peers of Glaxosmithkline Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Glaxosmithkline Pharmaceuticals Ltd?
The promotor/promotors of Glaxosmithkline Pharmaceuticals Ltd are D Sundaram, A A Nadkarni, P V Bhide, A N Roy, Subesh Williams, Renu S Karnad, Sunita Maheshwari, Manu Anand, Bhushan Akshikar, J. Chandy.
What has been 52-week high of Glaxosmithkline Pharmaceuticals Ltd stocks?
The highest price of Glaxosmithkline Pharmaceuticals Ltd stock is ₹3,148.00 in the last 52-week.
What is the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) today on NSE?
As on Apr 25, 2025 Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2802.7
What is the market cap of Glaxosmithkline Pharmaceuticals Ltd (GLAXO)?
The current market capitalisation of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) is 47,479.43 crores
What is Glaxosmithkline Pharmaceuticals Ltd Share symbol?
The symbol of Glaxosmithkline Pharmaceuticals Ltd is GLAXO.
What is the PE ratio of Glaxosmithkline Pharmaceuticals Ltd (GLAXO)?
The current PE ratio of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) is 55.28.
What is the PB ratio of Glaxosmithkline Pharmaceuticals Ltd (GLAXO)?
The current PB ratio of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) is 28.40.
Today’s High & Low share prices of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) on NSE?
Today, the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) on NSE touched a high of Rs 2944.8 and a low of Rs 2780
What price did Glaxosmithkline Pharmaceuticals Ltd (GLAXO) shares open on the NSE today?
On NSE, the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) opened at Rs 2941.5
What is the 52-week high of Glaxosmithkline Pharmaceuticals Ltd (GLAXO)?
The 52-week high price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) is Rs 3,148.00
What is the 52-week low of Glaxosmithkline Pharmaceuticals Ltd (GLAXO)?
The 52-week low price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) is Rs 1,921.00

bt_logoAbout Glaxosmi. Pharma

Glaxosmithkline Pharmaceuticals Ltd, incorporated in the year 1924, has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030, 91-022-24959595, 91-022-24959494. The main industry in which Glaxosmithkline Pharmaceuticals Ltd operates is Pharmaceuticals - Multinational.

Auditor/Auditors for Glaxosmithkline Pharmaceuticals Ltd is/are Deloitte Haskins & Sells LLP. In the main management, Renu S Karnad is chairman and A A Nadkarni is the company secretary for Glaxosmithkline Pharmaceuticals Ltd.

  • DS
    D SundaramIndependent Director
  • AAN
    A A NadkarniCompany Sec. & Compli. Officer
  • PVB
    P V BhideIndependent Director
  • ANR
    A N RoyIndependent Director
  • SW
    Subesh WilliamsNon Executive Director
  • RSK
    Renu S KarnadChairperson
  • SM
    Sunita MaheshwariIndependent Director
  • MA
    Manu AnandIndependent Director
  • BA
    Bhushan AkshikarManaging Director
  • JC
    J. ChandyWhole Time Director & CFO

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.